Plain-English translation of NCT06770023 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a special device called the Protek Solo Cannula, which is placed through the wall between the heart's chambers to help support the right side of your heart while you wait for a lung transplant. The device acts like a temporary mechanical support system, pumping blood from your heart to an external machine that helps oxygenate it before returning it to your body. This treatment is designed to keep very sick patients alive and stable until they can receive their lung transplant.
Patients waiting for lung transplants often develop severe weakness in the right side of their heart because of high blood pressure in the lungs. Current treatments with medications alone are not always strong enough, and there is no other good option to support the heart until a donor lung becomes available. This trial is testing whether this new device placement method can safely help these patients survive and stay stable during this critical waiting period.
You likely qualify if…
You likely don't qualify if…
If accepted into this trial, you would receive the Protek Solo Cannula device, which involves a specialized procedure to place it through the wall of your heart. You would then be supported by this device and an external heart support machine while waiting for your lung transplant. The research team will carefully monitor your heart function, blood work, and overall condition throughout your time on the device, with the goal of keeping you alive and stable until a donor lung becomes available for transplantation.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States
Phase
Safety & dosing
Sponsor
Mayo Clinic
Enrollment target
~4 participants
Started
June 2026
Primary completion
December 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ian A Makey, MD
Mayo Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.